Observational study on quality of life, safety, and effectiveness of first‐line cetuximab plus chemotherapy in <i><scp>KRAS</scp></i> wild‐type metastatic colorectal cancer patients: the ObservEr StudyCarmine Pinto, Francesco Di Costanzo, Enzo Maria Ruggeri et al.|Cancer Medicine|2016Cited by 26
Italian observational study in patients with metastatic colorectal cancer (mCRC) treated with first-line cetuximab based regimen (ObservEr study).Francesca Di Fabio, Carmine Pinto, Gerardo Rosati et al.|Journal of Clinical Oncology|2014Cited by 1